All stock lists
Aligos Therapeutics, Inc. (NASDAQ:ALGS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.16-0.41 (-15.95%)
Market cap
$11.8M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 16, 2020
Website
Insider Score
––Not scored
ALGS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
ALGS analyst forecast
Best analysts covering ALGS
- HC Wainwright & Co.33%success rate · -13.0% avg return · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ALGS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-03-11 |
ALGS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-05 | -2.49 | -1.91 | $440K | $169K |
| 2026-05-07 | -2.29 | -2.21 | $250K | $2.8M |
| 2026-08-06 | -1.09 | -0.14 | $24.7M | $27.8M |
| 2026-11-06 | -2.28 | -2.09 | $4.8M | $2.9M |
| 2027-03-04Upcoming | -1.92 | — | $538K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.